×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CLGN – collplant biotechnologies ltd. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CLGN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
09:00 am
clgn
CollPlant Biotechnologies Launches Redesigned Corporate Website
Medium
Report
CollPlant Biotechnologies Launches Redesigned Corporate Website
3/11
08:00 am
clgn
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
Low
Report
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
2/26
07:02 pm
clgn
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler [Yahoo! Finance]
Low
Report
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler [Yahoo! Finance]
2/26
08:00 am
clgn
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
Medium
Report
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
2/23
07:00 am
clgn
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
Medium
Report
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
2/17
07:00 am
clgn
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
High
Report
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
2/6
08:11 am
clgn
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering [Yahoo! Finance]
Neutral
Report
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering [Yahoo! Finance]
2/6
08:04 am
clgn
CollPlant Biotechnologies (NASDAQ:CLGN) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
Neutral
Report
CollPlant Biotechnologies (NASDAQ:CLGN) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
Date
Time
Symbol
Company Name
Action
%Chg
11/26/2025
07:30 am
clgn
collplant biotechnologies ltd. - ordinary shares
MISS
Report
8.3%
collplant biotechnologies ltd. - ordinary shares
8/20/2025
07:00 am
clgn
collplant biotechnologies ltd. - ordinary shares
MISS
Report
-20.0%
collplant biotechnologies ltd. - ordinary shares
5/28/2025
07:00 am
clgn
collplant biotechnologies ltd. - ordinary shares
BEAT
Report
76.2%
collplant biotechnologies ltd. - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
04:30 pm
clgn
Form 3 CollPlant Biotechnologie For: Mar 19 Filed by: Tal Yehiel
Low
Report
Form 3 CollPlant Biotechnologie For: Mar 19 Filed by: Tal Yehiel
3/18
10:22 am
clgn
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Lask Alisa
Low
Report
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Lask Alisa
3/18
10:21 am
clgn
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Penn Elan
Low
Report
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Penn Elan
3/18
10:20 am
clgn
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Havron Avraham
Low
Report
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Havron Avraham
3/18
10:18 am
clgn
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Bagley Bowman
Low
Report
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Bagley Bowman
3/18
10:17 am
clgn
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Abelis Bar Berta
Low
Report
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Abelis Bar Berta
3/18
10:15 am
clgn
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Seror Jasmine
Low
Report
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Seror Jasmine
3/18
10:13 am
clgn
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Bensimon Philippe
Low
Report
Form 3 CollPlant Biotechnologie For: Mar 18 Filed by: Bensimon Philippe
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/13
3D Systems and CollPlant Biotechnologies Join Forces to Accelerate Breakthroughs in Regenerative Medicine
13.2%
1/6 Form 6-K CollPlant Biotechnologie For: Jan 06 12.6%
5/28 CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece 11.4%
8/12 Form SC 13D/A CollPlant Biotechnologie Filed by: Sagy Ami 10.4%
4/7 Form 6-K CollPlant Biotechnologie For: Apr 07 7.6%
6/4 Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference 4.5%
12/3 COLLPLANT HOLDI/S (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock. 3.8%
3/9 Form D CollPlant Biotechnologie 3.0%
1/9 COLLPLANT HOLDI/S (NASDAQ: CLGN) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 3.0%
2/4 CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments 2.9%
1/6 Form 6-K CollPlant Biotechnologie For: Jan 06 12.6%
5/28 CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece 11.4%
8/12 Form SC 13D/A CollPlant Biotechnologie Filed by: Sagy Ami 10.4%
4/7 Form 6-K CollPlant Biotechnologie For: Apr 07 7.6%
6/4 Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference 4.5%
12/3 COLLPLANT HOLDI/S (NASDAQ: CLGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock. 3.8%
3/9 Form D CollPlant Biotechnologie 3.0%
1/9 COLLPLANT HOLDI/S (NASDAQ: CLGN) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 3.0%
2/4 CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments 2.9%
TOP News Decliners
3/6
Form 6-K CollPlant Biotechnologie For: Mar 06
-14.6%
11/5 Form SC 13D/A CollPlant Biotechnologie Filed by: Sagy Ami -9.3%
8/23 Form 6-K CollPlant Biotechnologie For: Aug 23 -6.6%
4/1 CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019 -5.8%
8/8 Form 6-K CollPlant Biotechnologie For: Aug 08 -2.9%
2/14 CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement -2.7%
11/27 COLLPLANT HOLDI/S (NASDAQ: CLGN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.6%
9/9 CollPlant Biotechnologies Closes on $5.5 Million Financing -2.5%
3/24 3D Bioprinting Market - Growth, Trends and Forecasts (2020 - 2025) -2.2%
5/22 Form 6-K CollPlant Holdings Ltd. For: May 22 -2.0%
11/5 Form SC 13D/A CollPlant Biotechnologie Filed by: Sagy Ami -9.3%
8/23 Form 6-K CollPlant Biotechnologie For: Aug 23 -6.6%
4/1 CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019 -5.8%
8/8 Form 6-K CollPlant Biotechnologie For: Aug 08 -2.9%
2/14 CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement -2.7%
11/27 COLLPLANT HOLDI/S (NASDAQ: CLGN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.6%
9/9 CollPlant Biotechnologies Closes on $5.5 Million Financing -2.5%
3/24 3D Bioprinting Market - Growth, Trends and Forecasts (2020 - 2025) -2.2%
5/22 Form 6-K CollPlant Holdings Ltd. For: May 22 -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: